
Opinion|Videos|October 16, 2024 (Updated: October 16, 2024)
Access Challenges: Bridging Insurance Gaps for MDD Innovations
Carmen Kosicek, MSN, PMHNP-BC shares her insights into insurance coverage, the role of specialty pharmacies, and patient advocacy efforts to improve access to novel MDD therapies.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Postmodern Worldview and Contemporary Psychiatry
2
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
3
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
4
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
5








